Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660172
What this trial is testing

Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01071837
What this trial is testing

APG101 in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Apogenix GmbH 84
Testing effectiveness (Phase 2)UnknownNCT05970302
What this trial is testing

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Who this might be right for
TislelizumabBevacizumabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Not applicableStudy completedNCT05321212
What this trial is testing

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

Who this might be right for
Carcinoma, Non-Small-Cell LungImmunotherapy
University Hospital, Brest 108
Testing effectiveness (Phase 2)Looking for participantsNCT06760039
What this trial is testing

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Sun Yat-sen University 112
Large-scale testing (Phase 3)UnknownNCT00948805
What this trial is testing

Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatment

Who this might be right for
Infertility
University of Sao Paulo 25
Not applicableStudy completedNCT03874637
What this trial is testing

FemPulse Therapy First-in-Human Experience

Who this might be right for
Urinary Bladder, Overactive
FemPulse Corporation 15
Testing effectiveness (Phase 2)Ended earlyNCT05537402
What this trial is testing

LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 1
Not applicableNot Yet RecruitingNCT07788053
What this trial is testing

Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori Infection

Who this might be right for
Helicobatcer PyloriFirst-Line Eradication
Chih-An Shih, MD 300
Testing effectiveness (Phase 2)Study completedNCT04547153
What this trial is testing

Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC

Who this might be right for
Gastric CancerBone Marrow MetastasisDisseminated Intravascular Coagulation
Sixth Affiliated Hospital, Sun Yat-sen University 24
Large-scale testing (Phase 3)Study completedNCT01720095
What this trial is testing

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Who this might be right for
Psychosis
Nova Scotia Health Authority 22
Testing effectiveness (Phase 2)UnknownNCT06078657
What this trial is testing

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)PD-1 Inhibitors
The First Affiliated Hospital of Zhengzhou University 46
Not applicableEnded earlyNCT01896973
What this trial is testing

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)

Who this might be right for
Benign Prostatic Hyperplasia (BPH)
HistoSonics, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT01048645
What this trial is testing

Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
National Institute of Cancerología 107
Large-scale testing (Phase 3)Study completedNCT02587195
What this trial is testing

Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nice 5
Testing effectiveness (Phase 2)UnknownNCT06308939
What this trial is testing

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

Who this might be right for
Metastatic Breast Cancer
Zhejiang Cancer Hospital 81
Large-scale testing (Phase 3)Looking for participantsNCT06452277
What this trial is testing

Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer 555
Not applicableStudy completedNCT01343901
What this trial is testing

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 210
Testing effectiveness (Phase 2)Looking for participantsNCT07478523
What this trial is testing

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

Who this might be right for
CholangiocarcinomaPancreatic Adenocarcinoma
University Hospital, Bordeaux 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05771480
What this trial is testing

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 142
Next Page